Safety and efficacy of transdermal buprenorphine for the relief of cancer pain Cho NaingKyan AungPeng Nam Yeoh Review 07 August 2013 Pages: 1963 - 1970
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients Andreas HochhausHagop Kantarjian Review Open access 13 August 2013 Pages: 1971 - 1984
Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study Andreas HochhausPhilipp D. le CoutreFrancis J. Giles Original Paper 22 September 2013 Pages: 1985 - 1993
Modulation of peripheral immune responses by paclitaxel–ifosfamide–cisplatin chemotherapy in advanced non-small-cell lung cancer Nikolaos KoufosDespina MichailidouNikolaos Tsavaris Original Paper 26 September 2013 Pages: 1995 - 2003
Intrapleural hyperthermic perfusion using distilled water at 48 °C for malignant pleural effusion Mingchen BaHui LongShuzhong Cui Original Paper 26 September 2013 Pages: 2005 - 2012
The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up Arfon G. M. T. PowellJenny FergusonJames J. Going Original Paper 26 September 2013 Pages: 2013 - 2020
Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients Jia-yan NiLin-feng XuJiang-hong Luo Original Paper 26 September 2013 Pages: 2021 - 2033
Scaling adult dose and schedule of anticancer agents to children Thomas H. Dawson Original Paper 27 September 2013 Pages: 2035 - 2045
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study Nicolai MaassNadia HarbeckOn behalf of the German Breast Group Original Paper 27 September 2013 Pages: 2047 - 2056
RETRACTED ARTICLE: siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer Donglei ZhouXun JiangLiesheng Lu Original Paper 28 September 2013 Pages: 2057 - 2070
Impact of chemotherapy and radiotherapy in childhood on fertility in adulthood: the FeCt—survey of childhood cancer survivors in Germany Simone ReinmuthCynthia HohmannAnja Borgmann-Staudt Original Paper 02 October 2013 Pages: 2071 - 2078
RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7) Emilie MalisseinElise MeunierSophie F. Doisneau-Sixou Original Paper 06 October 2013 Pages: 2079 - 2088
A survey of patterns of practice on palliative radiation therapy for bone metastasis in Korea Yoonsun ChungWoong Sub KoomYoon Jae Lee Original Paper 10 October 2013 Pages: 2089 - 2096
Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model Carina RiedigerGerhard WingenderJens Encke Original Paper 10 October 2013 Pages: 2097 - 2110
Impact of adding cisplatin to S-1 in elderly patients with advanced gastric cancer Tetsuji TerazawaSatoru IwasaYasuhiro Shimada Original Paper 16 October 2013 Pages: 2111 - 2116
Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma Zhou-Hong YaoGuang-Yan TianDian-Jie Lin Original Paper 23 October 2013 Pages: 2117 - 2123
Specific expression of k63-linked ubiquitination of calmodulin-like protein 5 in breast cancer of premenopausal patients Manuel DebaldFrank Alexander SchildbergGisela Walgenbach-Brünagel Original Paper 22 October 2013 Pages: 2125 - 2132
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer Peter NygrenMårten FryknäsRolf Larsson Rapid Communication Open access 18 October 2013 Pages: 2133 - 2140
